Seroatlas · Human Serome Atlas

NSDHL

Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating

Also known as: H105e3, NSDHL_HUMAN, SDR31E1, XAP104

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q15738
Gene
NSDHL
Ensembl
ENSG00000147383
Chromosome
X
Canonical length
373 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
Subcellular location
Endoplasmic reticulum,Lipid droplets
Quaternary structure
Homodimer

OverviewNCBI Gene

The protein encoded by this gene is localized in the endoplasmic reticulum and is involved in cholesterol biosynthesis. Mutations in this gene are associated with CHILD syndrome, which is a X-linked dominant disorder of lipid metabolism with disturbed cholesterol biosynthesis, and typically lethal in males. Alternatively spliced transcript variants with differing 5' UTR have been found for this gene. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

373 residues, UniProt reviewed canonical sequence.

>Q15738|NSDHL
     1  MEPAVSEPMR DQVARTHLTE DTPKVNADIE KVNQNQAKRC TVIGGSGFLG QHMVEQLLAR
    61  GYAVNVFDIQ QGFDNPQVRF FLGDLCSRQD LYPALKGVNT VFHCASPPPS SNNKELFYRV
   121  NYIGTKNVIE TCKEAGVQKL ILTSSASVIF EGVDIKNGTE DLPYAMKPID YYTETKILQE
   181  RAVLGANDPE KNFLTTAIRP HGIFGPRDPQ LVPILIEAAR NGKMKFVIGN GKNLVDFTFV
   241  ENVVHGHILA AEQLSRDSTL GGKAFHITND EPIPFWTFLS RILTGLNYEA PKYHIPYWVA
   301  YYLALLLSLL VMVISPVIQL QPTFTPMRVA LAGTFHYYSC ERAKKAMGYQ PLVTMDDAME
   361  RTVQSFRHLR RVK

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against NSDHL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Other membrane
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.28
Highest tissue expression
50 nTPM

Expression across tissuesHPA

Tissue

  • esophagus: 50 nTPM
  • liver: 47 nTPM
  • epididymis: 42 nTPM
  • adrenal gland: 37 nTPM
  • small intestine: 24 nTPM
  • vagina: 23 nTPM

Single-cell type

  • esophageal apical cells: 239 nCPM
  • oocytes: 147 nCPM
  • epididymal principal cells: 144 nCPM
  • esophageal suprabasal cells: 95 nCPM
  • breast lactating cells: 71 nCPM
  • esophageal basal cells: 54 nCPM

Immune cell

  • basophil: 21 nTPM
  • T-reg: 20 nTPM
  • NK-cell: 20 nTPM
  • classical monocyte: 20 nTPM
  • myeloid DC: 19 nTPM
  • memory B-cell: 19 nTPM

Brain region

  • pons: 27 nTPM
  • midbrain: 20 nTPM
  • medulla oblongata: 20 nTPM
  • thalamus: 19 nTPM
  • white matter: 19 nTPM
  • hypothalamus: 18 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about NSDHL.

Disease | AllUniProt

Conditions NSDHL is implicated in, by any mechanism.

Disease | GeneticClinVar

20 pathogenic / likely-pathogenic of 314 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.29
gnomAD pLI
0.96
gnomAD missense Z
0.87
DepMap mean gene effect
0.07
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of NSDHL in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads NSDHL as an antibody target. Whether an autoantibody or antibody against NSDHL could matter depends on whether native NSDHL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

NSDHL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label NSDHL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/NSDHL. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...